# US 2021/0082307 A1 · Products to facilitate smokers switching to a tobacco heating product or e-cigarettes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0082307 A1
- Document ID: US20210082307A1
- Status: Published application
- Kind: A1
- Application number: 17/107,314
- Filed: 2020-11-30
- Published: 2021-03-18
- Earliest claimed: 2018-07-27
- Assignees: Cabbacis LLC
- Inventors: Joseph PANDOLFINO
- Web page: https://patentgrep.com/patent/US20210082307A1

## CPC

- G09B 19/00: Teaching not covered by other main groups of this subclass (teaching or practice apparatus for gun-aiming or gun-laying F41G3/26)
- A24B 15/12: of reconstituted tobacco
- A24B 15/16: of tobacco substitutes
- A24B 15/167: in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
- A24B 15/302: {by natural substances obtained from animals or plants}
- A24F 40/20: Devices using solid inhalable precursors
- A24F 47/00: Smokers' requisites not otherwise provided for
- A24B 15/303: {Plant extracts other than tobacco}
- G09B: EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS (devices for psychotechnics or for testing reaction times A61B5/16; games, sports, amusements A63; projectors, projector screens G03B)
- A24B: MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24F: SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES (inhaling appliances for medical purposes, shaped like cigars, cigarettes or pipes A61M15/06)

## Abstract

The present disclosure relates to tobacco products, including methodology, devices and compositions, for assisting a smoker to transition from conventional tobacco cigarettes to either e-cigarettes or a tobacco heating device. Provided herein are methodology for switching, along with kits, products and apparatuses. The disclosure also provides methodology for regulating tetrahydrocannabinolic acid synthase expression, for use in producing cigarettes, reconstituted cannabis, and other products having reduced Δ9-tetrahydrocannabinolic acid.

## Claims

### Claim 1

A very low nicotine cigarette comprising:
a blended filler of low nicotine tobacco and very low Δ9-tetrahydrocannabinol (THC) Cannabis sativa,
wherein the very low THC Cannabis sativa comprises any of:
flowers of a Cannabis sativa plant,
leaves of a Cannabis sativa plant,
reconstituted cannabis sheet-comprising flowers, leaves or stems of a Cannabis sativa plant, and
reconstituted tobacco and cannabis comprising:
tobacco, and
flowers, leaves or stems of a Cannabis sativa plant,
wherein a content of the very low THC Cannabis sativa of the very low nicotine cigarette is at least 5 mg,
wherein a nicotine content of the very low nicotine cigarette is equal to or less than 2.0 mg, and
wherein a collective content of Δ9-tetrahydrocannabinolic acid (THCA) and Δ9-tetrahydrocannabinol (THC) of the very low THC Cannabis sativa in the very low nicotine cigarette is equal to or less than 1.25 mg/g.

### Claim 2 (depends on 1)

A kit for transitioning a smoker of conventional cigarettes to using a tobacco heating device, the kit comprising:
a plurality of the very low nicotine cigarettes according to claim 1,
a tobacco heating device,
tobacco sticks, and
information and recommendations for transitioning the smoker from the conventional cigarettes to using the tobacco heating device.

### Claim 3 (depends on 1)

A kit for transitioning a smoker of conventional cigarettes to using e-cigarettes, the kit comprising:
a plurality of the very low nicotine cigarettes according to claim 1,
e-cigarettes, and
information and recommendations for transitioning the smoker from the conventional cigarettes to using the e-cigarettes.

### Claim 4 (depends on 1)

The very low nicotine cigarette according to claim 1, further comprising at least 0.25 mg anatabine.

### Claim 5 (depends on 1)

The very low nicotine cigarette according to claim 1, further comprising at least 0.10 mg anabasine.
